Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Relay Therapeutics revenue
Relay Therapeutics's revenue is $10.0 million.
What is Relay Therapeutics's revenue?
- Relay Therapeutics's revenue growth from 2020 to 2024 is -87.89%.
- Relay Therapeutics has 159 employees, and the revenue per employee ratio is $62,937.
- Relay Therapeutics's peak quarterly revenue was $82.7M in 2020(q4).
- Relay Therapeutics peak revenue was $82.7M in 2020.
- Relay Therapeutics annual revenue for 2023 was 25.5M, 1,749.82% growth from 2022.
- Relay Therapeutics annual revenue for 2024 was 10.0M, -60.83% growth from 2023.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Relay Therapeutics historical revenue
Relay Therapeutics's peak revenue was $82.7M in 2020. The peak quarterly revenue was $82.7M in 2020(q4).
Relay Therapeutics's revenue increased from $82.7m in 2020 to $10.0M currently. That's a -87.89% change in annual revenue.
Relay Therapeutics annual revenue
Relay Therapeutics annual revenue over time
| Fiscal year / year | Relay Therapeutics revenue |
|---|---|
| 2020 | $82.7M |
| 2021 | $3.0M |
| 2022 | $1.4M |
| 2023 | $25.5M |
| 2024 | $10.0M |
Rate Relay Therapeutics' financial transparency
Relay Therapeutics annual growth
Relay Therapeutics saw the greatest revenue growth in 2022, when revenue increased by -54.41%.
Relay Therapeutics had the lowest revenue growth in 2021, when revenue changed by -96.34%.
Relay Therapeutics annual growth rate over time
| Year | Relay Therapeutics growth |
|---|---|
| 2021 | -96%↓ |
| 2022 | -54%↓ |
| 2023 | 1750%↑ |
| 2024 | -61%↓ |
Relay Therapeutics quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Relay Therapeutics quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2020 | - | - | - | $82.7M |
| 2021 | $952,000 | $844,000 | $666,000 | $567,000 |
| 2022 | $419,000 | $365,000 | $344,000 | $253,000 |
| 2023 | $226,000 | $119,000 | $25.2M | -$1,000 |
| 2024 | $10.0M | - | - | - |
Relay Therapeutics jobs nearby
Do you work at Relay Therapeutics?
Is Relay Therapeutics transparent about its revenue structure?
Relay Therapeutics financing
Relay Therapeutics received early financing of $57.0M on 2016-09-14.
| Series | Round size | Date |
|---|---|---|
| Series A | $57M | 09/2016 |
| Series B | $63M | 12/2017 |
| Series C | $400M | 12/2018 |
Relay Therapeutics investors
| Investors | Security type |
|---|---|
| Third Rock Ventures | Series A |
| Alexandria Venture | Series B |
| EcoR1 Capital, LLC | Series B |
| Third Rock Ventures | Series B |
| Biotechnology Value Fund | Series B |
| Section 32 | Series B |
| GV | Series B |
| Casdin Capital | Series B |
| Tavistock Group | Series C |
| EcoR1 Capital, LLC | Series C |
| Alexandria Venture | Series C |
| SoftBank Investment Advisers | Series C |
| Perceptive Advisors | Series C |
| Biotechnology Value Fund | Series C |
| Foresite Capital | Series C |
| GV | Series C |
| D. E. Shaw Research | Series C |
| Casdin Capital | Series C |
Relay Therapeutics competitors
Relay Therapeutics's top competitor, Athenex, earned an annual revenue of $102.8M.
Relay Therapeutics's smallest competitor is Synlogic with revenue of $8.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Erasca | - | $8.5M | 57 | - |
| Resverlogix | - | $1.6M | 20 | - |
| Stoke Therapeutics | - | $36.6M | 50 | - |
| Synlogic | - | $8,000 | 74 | - |
| Surface Oncology | - | $30.0M | 51 | - |
| Athenex | - | $102.8M | 575 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Relay Therapeutics highest paying jobs
Zippia gives an in-depth look into the details of Relay Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Relay Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Relay Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Relay Therapeutics. The data presented on this page does not represent the view of Relay Therapeutics and its employees or that of Zippia.
Relay Therapeutics may also be known as or be related to RELAY THERAPEUTICS, INC., Relay Therapeutics and Relay Therapeutics, Inc.